Latest Breaking News On - Inducement incentive award plan - Page 13 : comparemela.com

Crinetics Pharmaceuticals Announces January 2024 Inducement

SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, the Compensation.

Chas schultzCorey davisNatalie badilloCrinetics pharmaceuticals incCompensation committee of crinetic board directorsCorporate communicationsHead of corporate communicationsCrinetics pharmaceuticalsLifesci advisorsCompensation committeeCrinetic boardInducement incentive award planNasdaq listing ruleNasdaq global select marketSci advisorsNasdaq crnx

Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Corey davisChas schultzNatalie badilloHead of corporate communicationsCrinetics pharmaceuticals incCrinetics pharmaceuticalsCompensation committee of crinetic board directorsCorporate communicationsLifesci advisorsCrinetics pharmaceuticals announcesPharmaceuticals announces januaryGrants under nasdaq listing ruleCompensation committeeCrinetic boardInducement incentive award planNasdaq listing rule

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension , today announced.

Gossamer bio incCompensation committee of gossamer board directorsGossamer bioCompensation committeeInducement incentive award planNasdaq listing ruleNasdaq global select market

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Richard vincentCorey davisRebecca nolan olsonOncternal therapeutics incInducement incentive award planNasdaq ruleReceptor tyrosine kinase like orphan

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 /PRNewswire/ IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today.

Andres ruiz brisenoBiosciences incCompensation committeeInducement incentive award planNasdaq listing ruleNasdaq global select marketVice president